279 W. C. Little et al., “The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.” Journal of Cardiac Failure 11, no. 3 (April 2005): 191–95.

280 P. M. Keeney et al., “Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson’s disease cell model.” Human Gene Therapy 20, no. 8 (August 2009): 897–907.

281 S. Ellouze et al., “Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction.” American Journal of Human Genetics 83, no. 3 (September 2008): 373–87.

282 R. R. Thomas et al., “RhTFAM treatment stimulates mitochondrial oxidative metabolism and improves memory in aged mice.” Aging 4, no. 9 (September 2012): 620–35.

283 T.-Y. Lu et al., “Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells.” Nature Communications 4 (January 2013): 2307.

284 I. M. Conboy et al., “Rejuvenation of aged progenitor cells by exposure to a young systemic environment.” Nature 433, no. 7027 (February 2005): 760–64.

285 S. A. Villeda et al., “Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.” Nature Medicine 20, no. 6 (June 2014): 659–63.

286 A. Ocampo et al., “In vivo amelioration of age-associated hallmarks by partial reprogramming.” Cell 167, no. 7 (December 2016): 1719–33 e12.

287 A. Akesson et al., “Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study.” Journal of the American College of Cardiology 64, no. 13 (September 2014): 1299–306.

288 E. S. Ford et al., “Healthy living is the best revenge: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam study.” Archives of Internal Medicine 169, no. 15 (August 2009): 1355–62.

289 E. S. Ford et al., “Low-risk lifestyle behaviors and all-cause mortality: findings from the National Health and Nutrition Examination Survey III Mortality Study.” American Journal of Public Health 101, no. 10 (October 2011): 1922–29.

290 S. Yusuf et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.” Lancet 364, no. 9438 (January): 937–52.

291 S. E. Chiuve et al., “Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women.” JAMA 306, no. 1 (July 2011): 62–69.

292 A. M. Herskind et al., “The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870–1900.” Human Genetics 97, no. 3 (March 1996): 319–23.

293 S. Moalem, Het nut van ziekte (De Bezige Bij, 2007).

294 N. Barzilai et al., “The rationale for delaying aging and the prevention of age-related diseases.” Rambam Maimonides Medical Journal 3, no. 4 (October 2012): e0020.

295 L. A. Gavrilov et al., “Demographic consequences of defeating aging.” Rejuvenation Research 13, no. 2–3 (January): 329–34.

296 T. Parker-Pope, “For a healthy retirement, keep working.” The New York Times, October 19, 2009.

297 “Health and retirement study.” University of Michigan, hrsonline.isr.umich.edu.

298 C. Dufouil et al., “Older age at retirement is associated with decreased risk of dementia.” European Journal of Epidemiology 29, no. 5 (May 2014): 353–61.

299 M. C. Carlson et al., “Evidence for neurocognitive plasticity in at-risk older adults: the experience corps program.” Journals of Gerontology Series A, Biological Sciences and Medical Sciences 64, no. 12 (December 2009): 1275–82.

Крис Вербург, доктор медицины, – ученый из Центра междисциплинарных исследований имени Лео Апостела в Свободном университете Брюсселя; также он входит в преподавательский состав университета «Сингулярность», мозгового треста Кремниевой долины, который изучает возможности применения новых разрабатываемых технологий в борьбе с самыми сложными проблемами мира. Доктор Вербург работает над медицинскими процедурами, которые помогут увеличить продолжительность здоровой жизни и бороться с возрастными болезнями с помощью питания и самых современных биотехнологий. Он основал новую научную дисциплину, нутригеронтологию, изучающую диеты и правила, которые помогут замедлить старение и уменьшить риск возрастных заболеваний. Доктора Вербурга часто приглашают выступать с лекциями о новых разработках и сдвигах парадигм в медицине, здравоохранении, науках о старении и т. д.